PRECISION CANCER THERAPIES VOL 2 : IMMUNOLOGIC APPROACHES FOR THE TREATMENT OF LYMPHOID MALIGNANCIES

IMMUNOLOGIC APPROACHES FOR THE TREATMENT OF LYMPHOID MALIGNANCIES

From Concept to Practice - Precision Cancer Therapies Volume 2

This book presents timely and authoritative information on the development of precision cancer therapies as applied to hematologic malignancies

Lire la suite keyboard_arrow_right

Auteur(s) Stephen M Ansell, John Gribben, Owen O'Connor
Éditeur WILEY
Date 29/02/2024
Pages 496
Taille 21 x 27
Type Relié
ISBN 9781119824541

Description détaillée : IMMUNOLOGIC APPROACHES FOR THE TREATMENT OF LYMPHOID MALIGNANCIES

The Precision Cancer Therapies series focuses on how to understand and translate fundamental basic science into information that can be directly applied to patients to advance care. Each volume of the series integrates the relevant biological concepts and principles necessary for translating this science to practitioners of this science.

Who are the Authors of "Precision Cancer Therapies Volume Two : Immunologic Approaches for the Treatment of Lymphoid Malignancies" ?

Precision Cancer Therapies, Volume Two, focuses on sophisticated immunotherapies targeting cancers affecting the blood, bone marrow, and lymph nodes. Edited and authored by the foremost authorities in the field, this comprehensive reference text covers targeting of cell surface receptors, antibody-drug conjugates (ADC), targeting immune checkpoint, targeting macrophages, EBV-directed immunotherapies, tumor-associated antigens (TAA), and chimeric antigen receptor T-cells (CAR-T).

Divided into nine sections, Volume Two includes an overview of the history of immunotherapy development in cancer, as well as a concluding section addressing the mechanistic basis and role of immunomodulatory drugs, analytical tools to quantitate immune-mediated effects, and other topics in immunotherapy. Chapters on specific therapeutics or therapeutic classes include a basic explanation of the underlying pathway and target, the pharmacology of the drug/class, relevant preclinical and clinical data, and discussion of clinical management and potential predictive biomarkers of response.

This book also:

  • Delivers a definitive, state-of-the-art review of the relevant biology and its importance in the broader context of cancer biology
  • Focuses on agents that mediate cell killing in lymphoma through a variety of immunologic mechanisms
  • Covers FDA-approved drugs and their indications, as well as drugs currently in development
  • Provides information on monotherapy and combination therapy, summary tables of trials, and discussion of toxicity and efficacy
  • Includes boxed sections highlighting major unique points about the information in the chapter

Precision Cancer Therapies, Volume Two: Immunologic Approaches for the Treatment of Lymphoid Malignancies, From Concept to Practice is an indispensable resource for medical, scientific, and allied medical professionals, advanced students, and interested general readers with background knowledge in the subject.

Who are the Authors of "Precision Cancer Therapies Volume Two : Immunologic Approaches for the Treatment of Lymphoid Malignancies" ?

Stephen M. Ansell, MD, PhD, Consultant, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

John G. Gribben, MD, DSc, Hamilton-Fairley Chair of Medical Oncology, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK.

Owen A. O’Connor, MD, PhD, American Cancer Society Research Professor; Professor of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA.

Auteur(s): IMMUNOLOGIC APPROACHES FOR THE TREATMENT OF LYMPHOID MALIGNANCIES

Stephen M Ansell
Owen O'Connor
184,83 €

Sur commande

Expédition sous 10 à 20 jours

184,83 €

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

3D Secure

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email